Glader B E, Backer K
Am J Hematol. 1986 Oct;23(2):135-9. doi: 10.1002/ajh.2830230208.
It previously has been reported that red blood cells (RBC) of patients with Diamond-Blackfan syndrome (DBS) have increased activity of orotidine decarboxylase (ODC) and adenosine deaminase (ADA). The studies reported here compared the activity of these two enzymes in DBS erythrocytes, cord blood, and reticulocytes. The activity of ODC, although increased in some DBS erythrocytes, was not significantly different from that seen in cord RBC or reticulocytes. In contrast, RBC-ADA activity was increased in 23 of 26 DBS patients; and this enzyme elevation was distinct from that seen in cord blood and reticulocytes. Moreover, ADA activity was normal in 26 of 27 patients with transient erythroblastopenia of childhood (TEC). Taken together, these data indicate RBC-ADA activity is more sensitive than ODC as a marker of DBS. In addition, RBC-ADA activity continues to be useful for distinguishing DBS and TEC in most patients with RBC hypoplasia.
此前有报道称,先天性纯红细胞再生障碍性贫血(DBS)患者的红细胞(RBC)中乳清苷脱羧酶(ODC)和腺苷脱氨酶(ADA)的活性增加。本文报道的研究比较了这两种酶在DBS红细胞、脐血和网织红细胞中的活性。ODC的活性虽然在一些DBS红细胞中有所增加,但与脐血红细胞或网织红细胞中的活性没有显著差异。相比之下,26例DBS患者中有23例的红细胞ADA活性增加;并且这种酶活性升高与脐血和网织红细胞中的情况不同。此外,27例儿童暂时性红细胞生成减少症(TEC)患者中有26例的ADA活性正常。综上所述,这些数据表明,作为DBS的标志物,红细胞ADA活性比ODC更敏感。此外,在大多数红细胞发育不全的患者中,红细胞ADA活性仍然有助于区分DBS和TEC。